‘Antimicrobial resistance is invisible. I am not.’

References

1. Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199-226.  https://doi.org/10.1016/S0140-6736(24)01867-1  PMID: 39299261 
2. World Health Organization (WHO). Antimicrobial resistance. Geneva: WHO; 21 Nov 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
3. FAO. FAO, UNEP, WHO, WOAH. World AMR Awareness Week, 18-24 November 2024, Campaign guide. 9 September 2024. Available from: https://www.who.int/publications/m/item/world-amr-awareness-week-2024-campaign-guide
4. WHO Taskforce of AMR Survivors. Meaningful engagement of patients, survivors and carers in addressing antimicrobial resistance. 10 May 2024. Available from: https://www.who.int/publications/m/item/meaningful-engagement-of-patients--survivors-and-carers-in-addressing-antimicrobial-resistance
5. Lewnard JA, Charani E, Gleason A, Hsu LY, Khan WA, Karkey A, et al. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis. Lancet. 2024;403(10442):2439-54.  https://doi.org/10.1016/S0140-6736(24)00862-6  PMID: 38797180 
6. Först G, Giesen R, Fink G, Sehlbrede M, Wimmesberger N, Allen R, et al. An in-depth analysis of antimicrobial prescription quality via repeated point prevalence surveys in ten non-university hospitals in south-western Germany. Euro Surveill. 2024;29(46):2400156. PMID: 39544144 
7. Kelly M, de Falleur M, Allaoui EM, Bonacini L, Catry B, Latour K, et al. Antibiotic patterns in older adults: a comparative study of 65+ populations in and beyond belgian nursing homes, 2016-2022. Euro Surveill. 2024;29(46):2400148.  https://doi.org/10.2807/1560-7917.ES.2024.29.46.2400148 
8. Rubinić I, Leung VH, Diaz Högberg L, Monnet DL, Vlahović-Palčevski V, ESAC-Net study group. Measuring hospital antibiotic consumption in EU/EEA countries: comparison of different metrics, 2017 to 2021. Euro Surveill. 2024;29(46):2400317.  https://doi.org/10.2807/1560-7917.ES.2024.29.46.2400317 
9. Hassoun-Kheir N, Guedes M, Arieti F, Diletta Pezzani M, Primrose Gladstone P, Robotham JV, et al. Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies. Euro Surveill. 2024;29(47):2400212.  https://doi.org/10.2807/1560-7917.ES.2024.29.47.2400212 
10. Linkevicius M, Witteveen S, Buzea M, Flonta M, Indreas M, Nica M, et al. Genomic surveillance detects interregional spread of New Delhi metallo-beta-lactamase-1-producing Providencia stuartii in hospitals, Romania, December 2021 to September 2023. Euro Surveill. 2024;29(47):2400587.  https://doi.org/10.2807/1560-7917.ES.2024.29.47.2400587 
11. Witteveen S, Hans JB, Izdebski R, Hasman H, Samuelsen Ø, Dortet L, et al. Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Euro Surveill. 2024;29(23):2300616.  https://doi.org/10.2807/1560-7917.ES.2024.29.23.2300616  PMID: 38847120 
12. Kohlenberg A, Svartström O, Apfalter P, Hartl R, Bogaerts P, Huang TD, et al. Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024. Euro Surveill. 2024;29(47):2400727.  https://doi.org/10.2807/1560-7917.ES.2024.29.47.2400727 
13. Kaspersen H, Brouwer MSM, Nunez-Garcia J, Cárdenas-Rey I, AbuOun M, Duggett N, et al. A study of Escherichia coli collected between 2013-2020 from six European countries reveals differences in profile and distribution of critical antimicrobial resistance determinants within One-Health compartments. Euro Surveill. 2024;29(47):2400295.  https://doi.org/10.2807/1560-7917.ES.2024.29.47.2400295